Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Sapna Patel is a melanoma oncologist and associate professor at the University of Texas MD Anderson Cancer Center in Houston, Texas. She received her MD from the University of Texas Medical Branch in Galveston, Texas. Dr. Patel then completed her clinical internship and residency at the University of Colorado at Denver and Health Sciences Center in Denver, Colorado and went on to complete a clinical fellowship in medical oncology at the University of Texas MD Anderson Cancer Center.
Dr. Patel specializes in uveal melanoma with one of the largest clinical metastatic uveal melanoma practices in the world. She has led several investigator-initiated and multi-institutional clinical trials, including studies of targeted therapy, immunotherapy, T-cell therapy, and antibody-drug conjugates for uveal melanoma. Her lab work focuses on translational research, characterizing longitudinal molecular signatures in tumor samples from patients receiving treatment. She has received intramural and extramural funding including NIH and CPRIT grants.
Dr. Patel's goal is to develop effective therapies for metastatic disease, and to identify biomarkers to predict response to treatment. She is board-certified in medical oncology by the American Board of Internal Medicine.